A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Genmab
Beijing Biotech
Genmab
National Institutes of Health Clinical Center (CC)
Incyclix Bio
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
AstraZeneca
Terremoto Biosciences Inc.
Filamon LTD
Ensem Therapeutics
Eisai Inc.
PMV Pharmaceuticals, Inc
AstraZeneca
NeoImmuneTech
Eli Lilly and Company
Genmab
AstraZeneca
University of Florida
Essen Biotech
Essen Biotech
AstraZeneca
Second Life Therapeutics
Ocellaris Pharma, Inc.
Apollo Therapeutics Ltd
Acerand Therapeutics Limited
Tanabe Pharma America, Inc.
BicycleTx Limited
Pfizer
BicycleTx Limited
Incyte Corporation
Maastricht University Medical Center
Hadassah Medical Organization
Hadassah Medical Organization
LigaChem Biosciences, Inc.
Shanghai Escugen Biotechnology Co., Ltd
TCR2 Therapeutics
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
Cancer Research UK
University of California, Irvine
Medicenna Therapeutics, Inc.
OncoC4, Inc.
Numab Therapeutics AG
Esperas Pharma Inc.
AtlasMedx, Incorporated
NextCure, Inc.
Valerio Therapeutics